Focus topics

Researchers develop Omicron antibodies

China is entering the race to develop a viable antibody therapy against COVID-19. A Shanghai-based research team announced the development of a new type of antibody that is able to neutralize Omicron and future coronavirus variants. This could present a decisive edge against the virus in the race against the pandemic, said lead researcher Huang Jinghe of Shanghai’s Fudan University. According to a report in the South China Morning Post, the new antibody was assembled from components of two different antibodies produced by human immune cells. On their own, both types of antibodies would be useless against Omicron. But the artificially assembled version has had success in fighting the virus.

Continue reading now

Get 30 days of free access to the Professional Briefing to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Twitter downloads surge after protests
    Police track protestors via cell phone data
    Tribute to Jiang
    Protests and relaxations in Guangzhou